Pharmacological Effects of a Specific Leukotriene B4 Receptor Antagonist (VML 295) on Blood Leukocytes, Cutaneous Inflammation and Epidermal Proliferation

Publisher： Karger

E-ISSN： 1660-5535|13|2|75-85

ISSN： 1660-5527

Source： Skin Pharmacology and Physiology, Vol.13, Iss.2, 2000-03, pp. : 75-85

Disclaimer: Any content in publications that violate the sovereignty, the constitution or regulations of the PRC is not accepted or approved by CNPIEC.

Previous Menu Next

Abstract

Related content

Cutaneous Application of Leukotriene B4 as an in vivo Model of Psoriasis-Like Skin Inflammation: An Immunohistological Study

By  

Skin Pharmacology and Physiology, Vol. 27, Iss. 3, 2014-01 ,pp. : 120-126

Karger

Access to resources Recommend Favorite

Effects of Systemic Treatment with Liarozole on Cutaneous Inflammation, Epidermal Proliferation and Differentiation in Extensive Plaque Psoriasis

By  

Skin Pharmacology and Physiology, Vol. 11, Iss. 2, 1998-04 ,pp. : 70-79

Karger

Access to resources Recommend Favorite

Effects of RS-601, a Novel Leukotriene D4/Thromboxane A2 Dual Receptor Antagonist, on Asthmatic Responses in Guinea Pigs

By  

Pharmacology, Vol. 69, Iss. 1, 2003-08 ,pp. : 51-58

Karger

Access to resources Recommend Favorite

Cutaneous Inflammation and Proliferation in vitro: Differential Effects and Mode of Action of Topical Glucocorticoids

By  

Skin Pharmacology and Physiology, Vol. 13, Iss. 2, 2000-03 ,pp. : 93-103

Karger

Access to resources Recommend Favorite

The Effects of Inhaled KP-496, a Novel Dual Antagonist for Cysteinyl Leukotriene Receptor and Thromboxane A2 Receptor, on Allergic Asthmatic Responses in Guinea Pigs

By  

Pharmacology, Vol. 84, Iss. 4, 2009-09 ,pp. : 249-256

Karger

Access to resources Recommend Favorite